Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Change in Receivables: 2023-2025

Historic Change in Receivables for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to -$254,000.

  • Upstream Bio's Change in Receivables fell 361.86% to -$254,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $76,000, marking a year-over-year decrease of 77.78%. This contributed to the annual value of $515,000 for FY2024, which is 264.01% up from last year.
  • According to the latest figures from Q3 2025, Upstream Bio's Change in Receivables is -$254,000, which was down 168.46% from $371,000 recorded in Q2 2025.
  • In the past 5 years, Upstream Bio's Change in Receivables ranged from a high of $640,000 in Q1 2024 and a low of -$254,000 during Q3 2025.
  • In the last 3 years, Upstream Bio's Change in Receivables had a median value of -$20,500 in 2024 and averaged $52,250.
  • Within the past 5 years, the most significant YoY rise in Upstream Bio's Change in Receivables was 262.72% (2025), while the steepest drop was 361.86% (2025).
  • Upstream Bio's Change in Receivables (Quarterly) stood at -$167,000 in 2023, then skyrocketed by 103.59% to $6,000 in 2024, then plummeted by 361.86% to -$254,000 in 2025.
  • Its last three reported values are -$254,000 in Q3 2025, $371,000 for Q2 2025, and -$47,000 during Q1 2025.